AI assistant
Barclays PLC Major Shareholding Notification 2021
5250_rns_2021-05-06_e8b88c88-ad6e-42ab-822f-89c886ee4983.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
Form 8.3 -WILLIS TOWERS WATSON PLC - Amendment
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. |
| Company dealt in | WILLIS TOWERS WATSON PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
| Date of dealing | 4 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
| (1) | Relevant securities | ||||
| 1,694,365 | 1.31% | 165,883 | 0.13% | ||
| (2) | Derivatives (other than options): | ||||
| 72,359 | 0.06% | 0 | 0.00% | ||
| (3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
| 1,772,824 | 1.37% | 171,983 | 0.13% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
| Class of relevant security: | Long | Short | ||||
| Number | (%) | Number | (%) | |||
| (1) Relevant securities | ||||||
| (2) Derivatives (other than options) | ||||||
| (3) Options and agreements to purchase/sell | ||||||
| Total | ||||||
Ap20
3. DEALINGS (Note 4)
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 261.6200 USD |
| Purchase | 3 | 262.8700 USD |
| Purchase | 5 | 262.8750 USD |
| Purchase | 6 | 262.3750 USD |
| Purchase | 11 | 262.6972 USD |
| Purchase | 13 | 262.5684 USD |
| Purchase | 19 | 262.6334 USD |
| Purchase | 35 | 262.4231 USD |
| Purchase | 37 | 262.3089 USD |
| Purchase | 68 | 262.0100 USD |
| Purchase | 89 | 262.5397 USD |
| Purchase | 154 | 261.9174 USD |
| Purchase | 168 | 262.4309 USD |
| Purchase | 396 | 262.0774 USD |
| Purchase | 399 | 262.3891 USD |
| Purchase | 403 | 262.4128 USD |
| Purchase | 467 | 262.5353 USD |
| Purchase | 512 | 262.2181 USD |
| Purchase | 591 | 262.1929 USD |
| Purchase | 1,628 | 262.2570 USD |
| Purchase | 3,000 | 262.1650 USD |
| Purchase | 3,206 | 262.1479 USD |
| Purchase | 3,282 | 262.7790 USD |
| Purchase | 4,231 | 262.7800 USD |
| Purchase | 6,677 | 262.7520 USD |
| Purchase | 8,244 | 262.0176 USD |
| Purchase | 12,167 | 262.4181 USD |
| Sale | 1 | 259.6100 USD |
| Sale | 1 | 262.9200 USD |
| Sale | 1 | 262.2900 USD |
| Sale | 2 | 261.6200 USD |
| Sale | 3 | 262.1100 USD |
| Sale | 5 | 262.9300 USD |
| Sale | 5 | 262.1000 USD |
| Sale | 13 | 262.5684 USD |
| Sale | 50 | 262.0300 USD |
| Sale | 68 | 262.0100 USD |
| Sale | 86 | 263.0900 USD |
| Sale | 190 | 262.5036 USD |
| Sale | 200 | 262.6750 USD |
| Sale | 300 | 262.2600 USD |
| Sale | 300 | 261.9533 USD |
| Sale | 409 | 262.4102 USD |
| Sale | 593 | 262.1874 USD |
| Sale | 626 | 262.2230 USD |
| Sale | 700 | 262.2408 USD |
| Sale | 750 | 262.1300 USD |
| Sale | 800 | 262.3239 USD |
| Sale | 1,053 | 261.9958 USD |
| Sale | 1,168 | 262.1756 USD |
| Sale | 1,273 | 262.6338 USD |
| Sale | 1,500 | 262.0850 USD |
| Sale | 2,422 | 261.9846 USD |
| Sale | 4,000 | 262.2039 USD |
| Sale | 6,357 | 262.0512 USD |
| Sale | 9,909 | 262.4794 USD |
| Sale | 12,456 | 262.7800 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
| SWAP | Long | 71,000 | 262.7800 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option |
Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
| Date of disclosure | 6 May 2021 |
| Contact name | Large Holdings Regulatory Operations |
| Telephone number | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection (Note 10) |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005747/en/
BARCLAYS PLC